Metsera’s Amylin Analog Stars In Obesity Phase I

 
• By Joseph Haas
  
Young woman standing on scales at home. Weight loss concept
Metsera adds promising early data with amylin analog to its GLP-1 candidate • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Therapy Areas